[JANX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -25.63%
YoY- -166.11%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 2,048 2,845 1,813 2,365 1,589 1,616 1,159 46.21%
PBT -17,459 -16,065 -16,696 -16,888 -13,410 -13,416 -10,766 38.07%
Tax -453 -4,805 -2,652 -373 -264 -74 137 -
NP -17,459 -11,260 -14,044 -16,515 -13,146 -13,416 -10,766 38.07%
Tax Rate - - - - - - - -
Total Cost 19,507 14,105 15,857 18,880 14,735 15,032 11,925 38.87%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -852.49 -395.78 -774.63 -698.31 -827.31 -830.20 -928.90 -5.56%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.42 -0.27 -0.34 -0.40 -0.32 -0.33 -0.26 37.71%
EPS Diluted -0.42 -0.27 -0.34 -0.40 -0.32 -0.33 -0.26 37.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.